Subsidiaries Silence EContact Us>
Silence Therapeutics Silence Therapeutics
▼
205.00p (-3.00p)
Vol: 66055
(15-minute delayed)
View full stock quote


  • Home
  • About Us
  • Platform Technologies
  • Pipeline
  • Collaborations
  • Investor Relations
  • News & Events
  • RNAi Hub
  • Menu
  • About Us
    • Overview
    • Strategy
    • History
    • Management
    • Board Of Directors
    • Scientific Advisory Board
    • Careers
  • RNAI Platform
    • Overview
    • Delivery Platform
    • RNAi Platform
    • RNA Interference
    • Intellectual Property
    • Publications
    • Glossary
  • Pipeline
    • Overview
    • Pre-Clinical development
  • Collaborations
    • Overview
    • Silence's Strengths
    • Partnerships
    • Partnering Opportunities
  • Investor Relations
    • Overview
    • Press Releases
    • Reports and Disclosures
    • Analyst Coverage
  • News & Events
    • Press Releases
    • Events
    • In the News
    • Publications
  • RNAi Hub
  • Contact
  • RNA Interference
  • RNAi Platform
  • Delivery Platform
  • Intellectual Property
  • Publications
  • Glossary

Platform Technologies

Platform Technologies

Platform Technologies

Awaiting content

Silence News

  • 02.05.13

    Holding in Company

  • 02.05.13

    Holding in Company

  • 02.05.13

    Holding in Company

  • 02.05.13

    Holding in Company

  • 29.04.13

    Result of EGM

  • 19.09.12Silence Twitter

    Read more on our recent appointment of Michael Khan as Chief Medical Adviser on our Board of Directors via http://t.co/2n06ndLl
    244 days ago

  • 12.09.12Silence Twitter

    Silence Therapeutics was featured in the Daily Mail yesterday, full article via this link http://t.co/ymBzzY1M
    251 days ago



Quick Links

  • Home
  • About Us
  • Platform Technologies
  • Pipeline
  • Collaborations
  • Investor Relations
  • News & Events
  • RNAi HUB
  • Site Map

Contact

3 Shortlands
Hammersmith
London W6 8DA
United Kingdom


Tel:+44 (0) 333 9880 140
Fax:+44 (0) 795 731 8494
Silence Therapeutics

Copyright © 2013 Silence Therapeutics.
All rights reserved.

Terms of Use
Forward-Looking Statement